Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Sees Large D
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Sees Large Decrease in Short Interest
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Rating) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 2,870,000 shares, a decline of 9.2% from the April 30th total of 3,160,000 shares. Approximately 9.5% of the company’s stock are short sold. […]
Related Keywords
, Nasdaq, Maxim Group, Tower Research Capital, Topco Ltd, Renaissance Technologies, Brainstorm Cell Therapeutics Inc, Capital Management, Brainstorm Cell Therapeutics, Get Rating, Cell Therapeutics, Street Group, Research Capital, Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Brainstorm Cell Therapeutics Daily, Nasdaq Bcli, Bcli, Medical, Stocks, Options, Put, Call,